🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-09
Trial ID
NCT02991859
The purpose of the study is to determine the appropriate dose of fluticason...
Status
Completed
Location
Research Site
Start Date
2006-11
Trial ID
NCT00403286
This will be a multi-center, randomized, placebo-controlled parallel-group ...
Status
Completed
Location
Greenville Pharmaceutical research, Inc.
Start Date
2012-03
Trial ID
NCT01516073
Treatments Being Tested
The aim of this randomized, crossover clinical trial is to determine the ef...
Status
Completed
Location
USARIEM
Start Date
2019-10-06
Trial ID
NCT04111263
Treatments Being Tested
This is a randomized, multi-center, parallel-group, active-controlled, doub...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00394355
The primary objective of this study is to evaluate the efficacy and safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09
Trial ID
NCT01156792
Treatments Being Tested
This study was conducted to see if mometasone nasal spray is efficaceous fo...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT00783224
Treatments Being Tested
This study is to evaluate the safety and efficacy of fluticasone propionate...
Status
Completed
Location
Teva Investigational Site 13881
Start Date
2016-12-28
Trial ID
NCT02980133
Treatments Being Tested
The aim of this study is to determinate the equipotent doses of inhaled met...
Status
Completed
Location
Harald Lenz
Start Date
2019-04-23
Trial ID
NCT03894800
Treatments Being Tested
GSK3772847, an anti-interleukin (IL)33 receptor monoclonal antibody, is a n...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-14
Trial ID
NCT03207243
Treatments Being Tested